Prognostic Relevance of Aberrant DNA Methylation in G1 and G2 Pancreatic Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|100|1|26-34

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.100, Iss.1, 2014-07, pp. : 26-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunohistochemical Expression and Prognostic Value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 93, Iss. 4, 2011-04 ,pp. : 249-258

Karger

Access to resources Recommend Favorite

Prognostic and Predictive Roles of MGMT Protein Expression and Promoter Methylation in Sporadic Pancreatic Neuroendocrine Neoplasms

By  

Neuroendocrinology, Vol. 100, Iss. 1, 2014-07 ,pp. : 35-44

Karger

Access to resources Recommend Favorite

Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

By  

Neuroendocrinology, Vol. 103, Iss. 3-4, 2015-08 ,pp. : 345-353

Karger

Access to resources Recommend Favorite

Clinical and Prognostic Features of Rectal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 98, Iss. 3, 2013-11 ,pp. : 180-187

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 153-171

Karger

Access to resources Recommend Favorite